Elon Musk's Neuralink announced on Wednesday that it has received approval to begin its first clinical trial in Canada, testing a device designed to allow paralyzed individuals to operate digital devices just by thinking.

Axar.az reports that, citing Reuters, the brain chip company explained that the Canadian trial will focus on evaluating the safety and initial functionality of its implant, which allows people with quadriplegia (complete paralysis of all four limbs) to control external devices using their thoughts.

Founded in 2016 by Musk and a team of engineers, Neuralink is developing a brain chip interface that can be implanted into the skull. The company believes this technology could eventually help patients regain movement, communication abilities, and even restore their vision.